In human retinoblastoma Y79 cells okadaic acid–parthenolide co-treatment induces synergistic apoptotic effects, with PTEN as a key player

References

• Aerts I, Lumbroso-Le Rouic L, Gauthier-Villars M, Brisse H, Doz F, Desjardins L. Retinoblastoma. Orphanet J Rare Dis 2006; 1:31; http://dx.doi.org/10.1186/1750-1172-1-31; PMID: 16934146
   PubMed Web of Science ®Google Scholar
• Goodrich DW. The retinoblastoma tumor-suppressor gene, the exception that proves the rule. Oncogene 2006; 25:5233 - 43; http://dx.doi.org/10.1038/sj.onc.1209616; PMID: 16936742
   PubMed Web of Science ®Google Scholar
• Giacinti C, Giordano A. RB and cell cycle progression. Oncogene 2006; 25:5220 - 7; http://dx.doi.org/10.1038/sj.onc.1209615; PMID: 16936740
   PubMed Web of Science ®Google Scholar
• Melamud A, Palekar R, Singh A. Retinoblastoma. Am Fam Physician 2006; 73:1039 - 44; PMID: 16570739
   PubMed Web of Science ®Google Scholar
• Zhong X, Li Y, Peng F, Huang B, Lin J, Zhang W, Zheng J, Jiang R, Song G, Ge J. Identification of tumorigenic retinal stem-like cells in human solid retinoblastomas. Int J Cancer 2007; 121:2125 - 31; http://dx.doi.org/10.1002/ijc.22880; PMID: 17565741
   PubMed Web of Science ®Google Scholar
• Antoneli CB, Ribeiro KC, Steinhorst F, Novaes PE, Chojniak MM, Malogolowkin M. Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil. J Pediatr Hematol Oncol 2006; 28:342 - 5; http://dx.doi.org/10.1097/00043426-200606000-00004; PMID: 16794500
   PubMed Web of Science ®Google Scholar
• Jehanne M, Mercier G, Doz F. Monitoring of ototoxicity in young children receiving carboplatin for retinoblastoma. Pediatr Blood Cancer 2009; 53:1162; http://dx.doi.org/10.1002/pbc.22124; PMID: 19479791
   PubMed Web of Science ®Google Scholar
• Marees T, van Leeuwen FE, de Boer MR, Imhof SM, Ringens PJ, Moll AC. Cancer mortality in long-term survivors of retinoblastoma. Eur J Cancer 2009; 45:3245 - 53; http://dx.doi.org/10.1016/j.ejca.2009.05.011; PMID: 19493675
   PubMed Web of Science ®Google Scholar
• Giuliano M, Lauricella M, Vassallo E, Carabillò M, Vento R, Tesoriere G. Induction of apoptosis in human retinoblastoma cells by topoisomerase inhibitors. Invest Ophthalmol Vis Sci 1998; 39:1300 - 11; PMID: 9660477
   PubMed Web of Science ®Google Scholar
• Vento R, Giuliano M, Lauricella M, Carabillò M, Di Liberto D, Tesoriere G. Induction of programmed cell death in human retinoblastoma Y79 cells by C2-ceramide. Mol Cell Biochem 1998; 185:7 - 15; http://dx.doi.org/10.1023/A:1006836428202; PMID: 9746206
   PubMed Web of Science ®Google Scholar
• Vento R, D’Alessandro N, Giuliano M, Lauricella M, Carabillò M, Tesoriere G. Induction of apoptosis by arachidonic acid in human retinoblastoma Y79 cells: involvement of oxidative stress. Exp Eye Res 2000; 70:503 - 17; http://dx.doi.org/10.1006/exer.1998.0810; PMID: 10865999
   PubMed Web of Science ®Google Scholar
• Giuliano M, Lauricella M, Calvaruso G, Carabillò M, Emanuele S, Vento R, Tesoriere G. The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells. Cancer Res 1999; 59:5586 - 95; PMID: 10554039
   PubMed Web of Science ®Google Scholar
• Drago-Ferrante R, Santulli A, Di Fiore R, Giuliano M, Calvaruso G, Tesoriere G, Vento R. Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1. Int J Oncol 2008; 33:677 - 87; PMID: 18813780
   PubMed Web of Science ®Google Scholar
• D’Anneo A, Augello G, Santulli A, Giuliano M, di Fiore R, Messina C, Tesoriere G, Vento R. Paclitaxel and beta-lapachone synergistically induce apoptosis in human retinoblastoma Y79 cells by downregulating the levels of phospho-Akt. J Cell Physiol 2010; 222:433 - 43; http://dx.doi.org/10.1002/jcp.21983; PMID: 19918798
   PubMed Web of Science ®Google Scholar
• Pajak B, Gajkowska B, Orzechowski A. Molecular basis of parthenolide-dependent proapoptotic activity in cancer cells. Folia Histochem Cytobiol 2008; 46:129 - 35; http://dx.doi.org/10.2478/v10042-008-0019-2; PMID: 18519227
   PubMed Web of Science ®Google Scholar
• Kawasaki BT, Hurt EM, Kalathur M, Duhagon MA, Milner JA, Kim YS, Farrar WL. Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approach. Prostate 2009; 69:827 - 37; http://dx.doi.org/10.1002/pros.20931; PMID: 19204913
   PubMed Web of Science ®Google Scholar
• Guzman ML, Rossi RM, Karnischky L, Li X, Peterson DR, Howard DS, Jordan CT. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 2005; 105:4163 - 9; http://dx.doi.org/10.1182/blood-2004-10-4135; PMID: 15687234
   PubMed Web of Science ®Google Scholar
• Carlisi D, D’Anneo A, Angileri L, Lauricella M, Emanuele S, Santulli A, Vento R, Tesoriere G. Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation. J Cell Physiol 2011; 226:1632 - 41; http://dx.doi.org/10.1002/jcp.22494; PMID: 21413021
   PubMed Web of Science ®Google Scholar
• Koprowska K, Czyz M. [Molecular mechanisms of parthenolide’s action: Old drug with a new face]. Postepy Hig Med Dosw (Online) 2010; 64:100 - 14; PMID: 20354259
   PubMedGoogle Scholar
• Bialojan C, Takai A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem J 1988; 256:283 - 90; PMID: 2851982
   PubMed Web of Science ®Google Scholar
• Rossini GP, Sgarbi N, Malaguti C. The toxic responses induced by okadaic acid involve processing of multiple caspase isoforms. Toxicon 2001; 39:763 - 70; http://dx.doi.org/10.1016/S0041-0101(00)00202-6; PMID: 11137534
   PubMed Web of Science ®Google Scholar
• Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984; 22:27 - 55; http://dx.doi.org/10.1016/0065-2571(84)90007-4; PMID: 6382953
   PubMedGoogle Scholar
• Kim YR, Eom JI, Kim SJ, Jeung HK, Cheong JW, Kim JS, Min YH. Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells. J Pharmacol Exp Ther 2010; 335:389 - 400; http://dx.doi.org/10.1124/jpet.110.169367; PMID: 20699435
   PubMed Web of Science ®Google Scholar
• Kitagishi Y, Matsuda S. Redox regulation of tumor suppressor PTEN in cancer and aging (Review). [Review] Int J Mol Med 2013; 31:511 - 5; PMID: 23313933
   PubMed Web of Science ®Google Scholar
• Chang CJ, Freeman DJ, Wu H. PTEN regulates Mdm2 expression through the P1 promoter. J Biol Chem 2004; 279:29841 - 8; http://dx.doi.org/10.1074/jbc.M401488200; PMID: 15090541
   PubMed Web of Science ®Google Scholar
• Boubacar T, Fatou S, Fousseyni T, Mariam S, Fatoumata DT, Toumani S, Abdoul-Aziz D, Marouf KM. A 30-month prospective study on the treatment of retinoblastoma in the Gabriel Toure Teaching Hospital, Bamako, Mali. Br J Ophthalmol 2010; 94:467 - 9; http://dx.doi.org/10.1136/bjo.2009.159699; PMID: 19822911
   PubMed Web of Science ®Google Scholar
• Laurie NA, Shih CS, Dyer MA. Targeting MDM2 and MDMX in retinoblastoma. Curr Cancer Drug Targets 2007; 7:689 - 95; http://dx.doi.org/10.2174/156800907782418266; PMID: 18045074
   PubMed Web of Science ®Google Scholar
• Boutrid H, Jockovich ME, Murray TG, Piña Y, Feuer WJ, Lampidis TJ, Cebulla CM. Targeting hypoxia, a novel treatment for advanced retinoblastoma. Invest Ophthalmol Vis Sci 2008; 49:2799 - 805; http://dx.doi.org/10.1167/iovs.08-1751; PMID: 18326690
   PubMed Web of Science ®Google Scholar
• Rizzuti AE, Dunkel IJ, Abramson DH. The adverse events of chemotherapy for retinoblastoma: what are they? Do we know?. Arch Ophthalmol 2008; 126:862 - 5; http://dx.doi.org/10.1001/archopht.126.6.862; PMID: 18541855
   PubMed Web of Science ®Google Scholar
• Bhanot A, Sharma R, Noolvi MN. Natural sources as potential anti-cancer agents: A review. Intl J Phytomed 2011; 3:9 - 26
   Google Scholar
• Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 2002; 14:381 - 95; http://dx.doi.org/10.1016/S0898-6568(01)00271-6; PMID: 11882383
   PubMed Web of Science ®Google Scholar
• Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002; 296:1655 - 7; http://dx.doi.org/10.1126/science.296.5573.1655; PMID: 12040186
   PubMed Web of Science ®Google Scholar
• Yuan TL, Cantley LC. PI3K pathway alterations in cancer: variations on a theme. Oncogene 2008; 27:5497 - 510; http://dx.doi.org/10.1038/onc.2008.245; PMID: 18794884
   PubMed Web of Science ®Google Scholar
• Valentinis B, Baserga R. IGF-I receptor signalling in transformation and differentiation. Mol Pathol 2001; 54:133 - 7; http://dx.doi.org/10.1136/mp.54.3.133; PMID: 11376123
   PubMedGoogle Scholar
• Metz HE, Houghton AM. Insulin receptor substrate regulation of phosphoinositide 3-kinase. Clin Cancer Res 2011; 17:206 - 11; http://dx.doi.org/10.1158/1078-0432.CCR-10-0434; PMID: 20966354
   PubMed Web of Science ®Google Scholar
• Giuliano M, Vento R, Lauricella M, Calvaruso G, Carabillo M, Tesoriere G. Role of insulin-like growth factors in autocrine growth of human retinoblastoma Y79 cells. Eur J Biochem 1996; 236:523 - 32; http://dx.doi.org/10.1111/j.1432-1033.1996.00523.x; PMID: 8612625
   PubMedGoogle Scholar
• Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 1998; 273:13375 - 8; http://dx.doi.org/10.1074/jbc.273.22.13375; PMID: 9593664
   PubMed Web of Science ®Google Scholar
• Chalhoub N, Baker SJ. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 2009; 4:127 - 50; http://dx.doi.org/10.1146/annurev.pathol.4.110807.092311; PMID: 18767981
   PubMed Web of Science ®Google Scholar
• Yin Y, Shen WH. PTEN: a new guardian of the genome. Oncogene 2008; 27:5443 - 53; http://dx.doi.org/10.1038/onc.2008.241; PMID: 18794879
   PubMed Web of Science ®Google Scholar
• Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275:1943 - 7; http://dx.doi.org/10.1126/science.275.5308.1943; PMID: 9072974
   PubMed Web of Science ®Google Scholar
• Li L, Ross AH. Why is PTEN an important tumor suppressor?. J Cell Biochem 2007; 102:1368 - 74; http://dx.doi.org/10.1002/jcb.21593; PMID: 17972252
   PubMed Web of Science ®Google Scholar
• Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007; 129:1261 - 74; http://dx.doi.org/10.1016/j.cell.2007.06.009; PMID: 17604717
   PubMed Web of Science ®Google Scholar
• Wu B, Wang X, Chi ZF, Hu R, Zhang R, Yang W, Liu ZG. Ursolic acid-induced apoptosis in K562 cells involving upregulation of PTEN gene expression and inactivation of the PI3K/Akt pathway. Arch Pharm Res 2012; 35:543 - 8; http://dx.doi.org/10.1007/s12272-012-0318-1; PMID: 22477202
   PubMed Web of Science ®Google Scholar
• Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther 2005; 4:139 - 63; http://dx.doi.org/10.4161/cbt.4.2.1508; PMID: 15725726
   PubMed Web of Science ®Google Scholar
• Skulachev VP. Why are mitochondria involved in apoptosis? Permeability transition pores and apoptosis as selective mechanisms to eliminate superoxide-producing mitochondria and cell. FEBS Lett 1996; 397:7 - 10; http://dx.doi.org/10.1016/0014-5793(96)00989-1; PMID: 8941703
   PubMed Web of Science ®Google Scholar
• Valdiglesias V, Laffon B, Pásaro E, Cemeli E, Anderson D, Méndez J. Induction of oxidative DNA damage by the marine toxin okadaic acid depends on human cell type. Toxicon 2011; 57:882 - 8; http://dx.doi.org/10.1016/j.toxicon.2011.03.005; PMID: 21396392
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol 1983; 32:671 - 6
   Google Scholar